While in other cancers chemotherapy is reported to upregulate NK cell-activating ligands, a comparison of pre- and post-chemotherapy OS tissue sections provided evidence for either unaltered or decreased expression of MICA, CD112, and CD155 after chemotherapy [43]. Here, MICA is linked to cancer.